Progesterone for acute traumatic brain injury

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 12, 2016, Pages

  Ma, Junpeng ^a   Huang, Siqing ^a   Qin, Shu ^a   You, Chao ^a   Zeng, Yunhui ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROGESTERONE; NEUROPROTECTIVE AGENT;

CLINICAL OUTCOME; DISABILITY; FOLLOW UP; GLASGOW OUTCOME SCALE; HOSPITAL MORTALITY; HUMAN; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; THERAPY EFFECT; TRAUMATIC BRAIN INJURY; BRAIN INJURIES; DRUG EFFECTS; GLASGOW COMA SCALE; INJURY SCALE; INTRACRANIAL PRESSURE; META ANALYSIS; MORTALITY; RISK;

BRAIN INJURIES; DISABILITY EVALUATION; GLASGOW COMA SCALE; HUMANS; INJURY SEVERITY SCORE; INTRACRANIAL PRESSURE; NEUROPROTECTIVE AGENTS; PROGESTERONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK;

EID: 85006983481     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008409.pub4     Document Type: Review

References (53)

1. Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD. A clinical trial of progesterone for severe traumatic brain injury. The New England Journal of Medicine 2014;371:2467-76. [2957087]
2. Wright DW, Kellermann AL, Hertzberg VS, Clark PL, Frankel M, Goldstein FC. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Annals of Emergency Medicine 2007;49:391-402. [2957089]
3. Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M. Very early administration of progesterone for acute traumatic brain injury. The New England Journal of Medicine 2014;371:2457-66. [2957091]
4. Xiao GM, Wei J, Wu ZH. Clinical study on the therapeutic effects and mechanism of progesterone in the treatment for acute severe head injury. Zhonghua Wai Ke Za Zhi 2007;45(2):106-8. [2957093]
5. Xiao G, Wei J, Yan W, Wang W, Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Critical Care 2008;12:R61. [2957095]
6. Abokhabar H, Abouelela A, Mousa S. Impact of progesterone administration on outcome of patients with severe traumatic brain injury. Intensive Care Medicine. 2012. [4492563]
7. Aminmansour B, Nikbakht H, Ghorbani A, Rezvani M, Rahmani P, Torkashvand M. Comparison of the administration of progesterone versus progesterone and vitamin D in improvement of outcomes in patients with traumatic brain injury: a randomized clinical trial with placebo group. Advanced Biomedical Research 2012;1:58. [2957097]
8. Mofid B, Soltani Z, Khaksari M, Shahrokhi N, Nakhaee N, Karamouzian S. What are the progesterone-induced changes of the outcome and the serum markers of injury, oxidant activity and inflammation in diffuse axonal injury patients?. International Immunopharmacology 2016;32:103-10. [4492565]
9. Raheja A, Sinha S, Samson N, Bhoi S, Subramanian A, Sharma P. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial. Journal of Neurosurgery 2016;125:631-41. [4492567]
10. Shakeri M, Boustani MR, Pak N, Panahi F, Salehpour F, Lotfinia I. Effect of progesterone administration on prognosis of patients with diffuse axonal injury due to severe head trauma. Clinical Neurology and Neurosurgery 2013;115:2019-22. [2957099]
11. Wright DW, Ritchie JC, Mullins RE, Kellermann AL, Denson DD. Steady-state serum concentrations of progesterone following continuous intravenous infusion in patients with acute moderate to severe traumatic brain injury. Journal of Clinical Pharmacology 2005;45:640-8. [2957101]
12. Sinha S. A clinical trial of progesterone with or without hypothermia in patients with severe head injury [A randomized placebo controlled trial (factorial design) of progesterone with or without hypothermia in subjects with acute severe traumatic brain injury]. www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=1048 2011 (accessed 30 September 2016). [4492569]
13. Sinha S. A clinical trial to Investigate the efficacy of progesterone in patients with severe traumatic brain injury [A randomized, placebo-controlled study to investigate the efficacy of progesterone in patients with severe traumatic brain injury]. www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=3871 2013 (accessed 30 September 2016). [4492571]
14. Khaksari M. Effect of female sex hormones on traumatic brain injury [Evaluation of the efficacy and probable mechanism of estrogen and progesteron on the complications of moderate and severe diffuse traumatic brain injury in patients admitted in Kerman Shahid Bahonar Hospital: a clinical trial]. www.irct.ir/searchresult.php?id=17356&number=1 2014 (accessed 30 September 2016). [4492572]
15. Alali AS, Vavrek D, Barber J, Dikmen S, Nathens AB, Temkin NR. Comparative study of outcome measures and analysis methods for traumatic brain injury trials. Journal of Neurotrauma 2015;32:581-9.
16. Alderson P, Roberts I. Corticosteroids for acute traumatic brain injury. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD000196.pub2]
17. Allolio B, Oremus M, Reincke M, Schaeffer HJ, Winkelmann W, Heck G, et al. High-dose progesterone infusion in healthy males: evidence against antiglucocorticoid activity of progesterone. European Journal of Endocrinology 1995;133:696-700.
18. Arango MF, Bainbridge D. Magnesium for acute traumatic brain injury. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD005400.pub3]
19. Brotfain E, Gruenbaum SE, Boyko M, Kutz R, Zlotnik A, Klein M. Neuroprotection by estrogen and progesterone in traumatic brain injury and spinal cord injury. Current Neuropharmacology 2016;14:641-53.
20. De Nicola AF, Gonzalez Deniselle MC, Garay L, Meyer M, Gargiulo-Monachelli G, Guennoun R. Progesterone protective effects in neurodegeneration and neuroinflammation. Journal of Neuroendocrinology 2013;25:1095-103.
21. Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Available from www.fda.gov.
22. Geddes RI, Peterson BL, Stein DG, Sayeed I. Progesterone treatment shows benefit in female rats in a pediatric model of controlled cortical impact injury. PLOS One 2016;11:e0146419.
23. Ghajar J. Traumatic brain injury. Lancet 2000;356:923-9.
24. Goldfien A. The gonadal hormones and inhibitors. Basic and Clinical Pharmacology. 4th Edition. Norwalk, CT: Appleton and Lange: Katzung BG, 1989:493-516.
25. GRADE working group. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490-7.
26. Gultekin R, Huang S, Clavisi O, Pattuwage L, König TC, Gruen R. Pharmacological interventions in traumatic brain injury: can we rely on systematic reviews for evidence?. Injury 2016;47:516-24.
27. He L, Zhang X, Wei X, Li Y. Progesterone attenuates aquaporin-4 expression in an astrocyte model of ischemia/reperfusion. Neurochemical Research 2014;39:2251-61.
28. Higgins JPT, Green S, editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
29. Hong Y, Wang X, Sun S, Xue G, Li J, Hou Y. Progesterone exerts neuroprotective effects against Aβ-induced neuroinflammation by attenuating ER stress in astrocytes. International Immunopharmacology 2016;33:83-9.
30. Hsieh JT, Lei B, Sheng H, Venkatraman T, Lascola CD, Warner DS. Sex-specific effects of progesterone on early outcome of intracerebral hemorrhage. Neuroendocrinology 2016;103:518-30.
31. Hyder AA, Wunderlich CA, Puvanachandra P, Gururaj G, Kobusingye OC. The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation 2007;22:341-53.
32. Li X, Zhang J, Zhu X, Wang P, Wang X, Li D. Progesterone reduces inflammation and apoptosis in neonatal rats with hypoxic ischemic brain damage through the PI3K/Akt pathway. International Journal of Clinical and Experimental Medicine 2015;8:8197-203.
33. Luoma JI, Kelley BG, Mermelstein PG. Progesterone inhibition of voltage-gated calcium channels is a potential neuroprotective mechanism against excitotoxicity. Steroids 2011;76:845-55.
34. Maas AI, Menon DK, Lingsma HF, Pineda JA, Sandel ME, Manley GT. Re-orientation of clinical research in traumatic brain injury: report of an international workshop on comparative effectiveness research. Journal of Neurotrauma 2012;29:32-46.
35. McGarry LJ, Thompson D. Outcomes and costs of acute treatment of traumatic brain injury. Journal of Trauma 2002;53(6):1152-9.
36. Menon DK, Maas AI. Traumatic brain injury in 2014. Progress, failures and new approaches for TBI research. Nature Reviews Neurology 2015;11:71-2.
37. Meyfroidt G, Taccone FS. Another failed attempt of neuroprotection: progesterone for moderate and severe traumatic brain injury. Minerva Anestesiologica 2016;82:486-91.
38. Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. Journal of Basic and Clinical Pharmacy 2016;7:27-31.
39. Poon W, Vos P, Muresanu D, Vester J, von Wild K, Homberg V. Cerebrolysin Asian Pacific trial in acute brain injury and neurorecovery: design and methods. Journal of Neurotrauma 2015;32:571-80.
40. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
41. Roberts I, Ker K, Edwards P, Beecher D, Manno D, Sydenham E. The knowledge system underpinning health care is not fit for purpose and must change. BMJ 2015;350:h2463.
42. Schumacher M, Baulieu EE. Neurosteroids: synthesis and functions in the central and peripheral nervous systems. Ciba Foundation Symposium 1995;191:90-106.
43. Singh M, Su C. Progesterone and neuroprotection. Hormones and Behavior 2013;63:284-90.
44. Soltani Z, Khaksari M, Shahrokhi N, Mohammadi G, Mofid B, Vaziri A. Effect of estrogen and/or progesterone administration on traumatic brain injury-caused brain edema: the changes of aquaporin-4 and interleukin-6. Journal of Physiology and Biochemistry 2016;72:33-44.
45. Stein DG. Progesterone exerts neuroprotective effects after brain injury. Brain Research Reviews 2008;57(2):386-97.
46. Stein DG. Embracing failure: what the Phase III progesterone studies can teach about TBI clinical trials. Brain Injury 2015;29:1259-72.
47. Wali B, Ishrat T, Won S, Stein DG, Sayeed I. Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study. Brain 2014;137:486-502.
48. Wali B, Sayeed I, Guthrie DB, Natchus MG, Turan N, Liotta DC. Evaluating the neurotherapeutic potential of a water-soluble progesterone analog after traumatic brain injury in rats. Neuropharmacology 2016;109:148-58.
49. Wang X, Zhang J, Yang Y, Dong W, Wang F, Wang L. Progesterone attenuates cerebral edema in neonatal rats with hypoxic-ischemic brain damage by inhibiting the expression of matrix metalloproteinase-9 and aquaporin-4. Experimental and Therapeutic Medicine 2013;6:263-7.
50. Webster KM, Wright DK, Sun M, Semple BD, Ozturk E, Stein DG. Progesterone treatment reduces neuroinflammation, oxidative stress and brain damage and improves long-term outcomes in a rat model of repeated mild traumatic brain injury. Journal of Neuroinflammation 2015;12:238.
51. Yousuf S, Atif F, Sayeed I, Wang J, Stein DG. Neuroprotection by progesterone after transient cerebral ischemia in stroke-prone spontaneously hypertensive rats. Hormones and Behavior 2016;84:29-40.
52. Junpeng M, Huang S, Qin S. Progesterone for acute traumatic brain injury. Cochrane Database of Systematic Reviews 2011, Issue 1. [DOI: 10.1002/14651858.CD008409.pub2]
53. Ma J, Huang S, Qin S, You C. Progesterone for acute traumatic brain injury. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD008409.pub3]